| Date |
Federal Register Citation |
Description |
|
12/12/1980 |
45FR82014
|
Advance Notice of Proposed
Rulemaking |
|
2/6/1981 |
46FR11292
|
Correction: Advance Notice of Proposed
Rulemaking |
|
5/5/1981 |
46FR25107
|
Extension of Comment Period: Advance Notice of Proposed
Rulemaking |
|
2/3/1995 |
60FR6713
[HTML] |
Availability: Guidance for development of
vaginal contraceptive drugs |
|
2/3/1995 |
60FR6892
[HTML] |
Proposed Rule: All products are nonmonograph
because final formulation effectiveness test needed |
|
10/30/1996 |
61FR55990
|
Notice: Advisory Committee meeting on
effectiveness |
|
12/19/1996 |
61FR66953
[HTML] |
Reopening of Administative Record: 10/30/1996
notice |
| 4/22/1998 |
63FR19799
|
Final
Rule: Classifies category II and III ingredients
without data as nonmonograph |
| 5/9/2002 |
67FR31123
|
Final
Rule: Classifies octoxynol 9 as nonmonograph |
| 1/16/2003 |
68FR2254
[HTML]
|
Proposed Rule: Requires warning that products do
not protect against STDs |
| 12/31/2003 |
68FR75585
[HTML]
|
Call for Data: Miscellaneous OTC drug products |
| 12/19/2007 |
72FR71769
[HTML]
|
Final Rule: Required labeling for products containing nonoxynol 9 |
